Beta 3 Agonist Treatment in Heart Failure-2

Clinical trial NCT03926754 · COMPLETED

Trial details

NCT number: NCT03926754
Sponsor: Henning Bundgaard
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction NYHA Class III-IV

Start date: 2017-01-23
Primary completion: 2021-01-21
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.